Salud ósea en pacientes con distrofia muscular de Duchenne

Juan David Lasprilla-Tovar; Juan Carlos Prieto; Norma Carolina Barajas-Viracachá; Paulo César Becerra-Ortiz; Edna Julieth Bobadilla-Quesada; Carlos Ernesto Bolaños-Almeida; José Manuel Cañón-Zambrano; Sandra Milena Castellar-Leones; Manuel Huertas-Quiñones; Jenny Libeth Jurado-Hernández; Nicolás J. Laza-Gutiérrez; Isabel C. Londoño Ossa; Blair Ortiz-Giraldo; Fernando Ortiz-Corredor; Sandra Janeth Ospina-Lagos; Carolina Rivera-Nieto; Edicson Ruiz-Ospina; Felipe Ruiz-Botero; María Claudia Salcedo-Maldonado; Diana Pilar Soto-Peña; Fernando Suárez-Obando; Lina Marcela Tavera-Saldaña; María Julia Torres-Nieto; Diana Carolina Sánchez-Peñarete

doi:10.12804/revistas.urosario.edu.co/revsalud/a.13614

Salud ósea en pacientes con distrofia muscular de Duchenne

Juan David Lasprilla-Tovar
, Juan Carlos Prieto
, Norma Carolina Barajas-Viracachá
, Paulo César Becerra-Ortiz
, Edna Julieth Bobadilla-Quesada
, Carlos Ernesto Bolaños-Almeida
, José Manuel Cañón-Zambrano
, Sandra Milena Castellar-Leones
, Manuel Huertas-Quiñones
, Jenny Libeth Jurado-Hernández
, Nicolás J. Laza-Gutiérrez
, Isabel C. Londoño Ossa
, Blair Ortiz-Giraldo
, Fernando Ortiz-Corredor
, Sandra Janeth Ospina-Lagos
, Carolina Rivera-Nieto
, Edicson Ruiz-Ospina
, Felipe Ruiz-Botero
, María Claudia Salcedo-Maldonado
, Diana Pilar Soto-Peña

Fernando Suárez-Obando, Lina Marcela Tavera-Saldaña, María Julia Torres-Nieto, Diana Carolina Sánchez-Peñarete

Instituto de Genética Humana

Fundación Hospital Pediátrico la Misericordia
Clínica Marly Jorge Cavelier Gaviria
Fundación Cardiovascular de Colombia
SOMEFYR
Hospital Universitario San Ignacio
Instituto Neurológico de Colombia
Junta de Enfermedades Neuromusculares de Biotecgen
Universidad Nacional de Colombia
University Clinic
Hospital Militar Central. Sante Fe
Especialista en Docencia Universitaria Bogotá
NeuroXtimular S. A. S. IPS
Universidad del Valle
Fundacion Clinica Infantil Club Noel
Hospital Universitario San Vicente Fundación
Universidad ICESI
Junta de Enfermedades Neuromusculares del Instituto Roosevelt
Instituto Roosevelt
Neuroconexion IPS
Universidad del Quindío
Consultorio particular

Producción: Contribución a una revista › Artículo › revisión exhaustiva

Resumen

Patients with Duchenne muscular dystrophy are treated with glucocorticoids aiming to modify the natural history of the disease. However, their prolonged use is associated with growth disturbances, alterations in skeletal development and increased fracture rates. Additionally, patients with Duchenne muscular dystrophy have increased bone fragility with changes in bone mass that may or may not be the result of glucocorticoid use. This fragility increases the risk of fractures, thus necessitating proper diagnosis, follow-up, and treatment of these patients. This review describes how to adequately assess and manage bone health in patients with dmd. © 2025, Universidad del Rosario. All rights reserved.

Título traducido de la contribución	Bone Health in Patients with Duchenne Muscular Dystrophy
Idioma original	Español
Publicación	Revista Ciencias de la Salud
Volumen	23
N.º	Special Issue
DOI	https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.13614
Estado	Publicada - 22 abr 2025

Palabras clave

Duchenne muscular dystrophy
bone
health

Acceder al documento

10.12804/revistas.urosario.edu.co/revsalud/a.13614

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

Lasprilla-Tovar, J. D., Prieto, J. C., Barajas-Viracachá, N. C., Becerra-Ortiz, P. C., Bobadilla-Quesada, E. J., Bolaños-Almeida, C. E., Cañón-Zambrano, J. M., Castellar-Leones, S. M., Huertas-Quiñones, M., Jurado-Hernández, J. L., Laza-Gutiérrez, N. J., Londoño Ossa, I. C., Ortiz-Giraldo, B., Ortiz-Corredor, F., Ospina-Lagos, S. J., Rivera-Nieto, C., Ruiz-Ospina, E., Ruiz-Botero, F., Salcedo-Maldonado, M. C., ... Sánchez-Peñarete, D. C. (2025). Salud ósea en pacientes con distrofia muscular de Duchenne. Revista Ciencias de la Salud, 23(Special Issue). https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.13614

@article{7c0a3ed0ba9840618b1d2eebcea8b046,

title = "Salud {\'o}sea en pacientes con distrofia muscular de Duchenne",

abstract = "Patients with Duchenne muscular dystrophy are treated with glucocorticoids aiming to modify the natural history of the disease. However, their prolonged use is associated with growth disturbances, alterations in skeletal development and increased fracture rates. Additionally, patients with Duchenne muscular dystrophy have increased bone fragility with changes in bone mass that may or may not be the result of glucocorticoid use. This fragility increases the risk of fractures, thus necessitating proper diagnosis, follow-up, and treatment of these patients. This review describes how to adequately assess and manage bone health in patients with dmd. {\textcopyright} 2025, Universidad del Rosario. All rights reserved.",

keywords = "Duchenne muscular dystrophy, bone, health",

author = "Lasprilla-Tovar, \{Juan David\} and Prieto, \{Juan Carlos\} and Barajas-Viracach{\'a}, \{Norma Carolina\} and Becerra-Ortiz, \{Paulo C{\'e}sar\} and Bobadilla-Quesada, \{Edna Julieth\} and Bola{\~n}os-Almeida, \{Carlos Ernesto\} and Ca{\~n}{\'o}n-Zambrano, \{Jos{\'e} Manuel\} and Castellar-Leones, \{Sandra Milena\} and Manuel Huertas-Qui{\~n}ones and Jurado-Hern{\'a}ndez, \{Jenny Libeth\} and Laza-Guti{\'e}rrez, \{Nicol{\'a}s J.\} and \{Londo{\~n}o Ossa\}, \{Isabel C.\} and Blair Ortiz-Giraldo and Fernando Ortiz-Corredor and Ospina-Lagos, \{Sandra Janeth\} and Carolina Rivera-Nieto and Edicson Ruiz-Ospina and Felipe Ruiz-Botero and Salcedo-Maldonado, \{Mar{\'i}a Claudia\} and Soto-Pe{\~n}a, \{Diana Pilar\} and Fernando Su{\'a}rez-Obando and Tavera-Salda{\~n}a, \{Lina Marcela\} and Torres-Nieto, \{Mar{\'i}a Julia\} and S{\'a}nchez-Pe{\~n}arete, \{Diana Carolina\}",

year = "2025",

month = apr,

day = "22",

doi = "10.12804/revistas.urosario.edu.co/revsalud/a.13614",

language = "Espa{\~n}ol ",

volume = "23",

journal = "Revista Ciencias de la Salud",

issn = "1692-7273",

publisher = "Universidad del Rosario",

number = "Special Issue",

}

Lasprilla-Tovar, JD, Prieto, JC, Barajas-Viracachá, NC, Becerra-Ortiz, PC, Bobadilla-Quesada, EJ, Bolaños-Almeida, CE, Cañón-Zambrano, JM, Castellar-Leones, SM, Huertas-Quiñones, M, Jurado-Hernández, JL, Laza-Gutiérrez, NJ, Londoño Ossa, IC, Ortiz-Giraldo, B, Ortiz-Corredor, F, Ospina-Lagos, SJ, Rivera-Nieto, C, Ruiz-Ospina, E, Ruiz-Botero, F, Salcedo-Maldonado, MC, Soto-Peña, DP, Suárez-Obando, F, Tavera-Saldaña, LM, Torres-Nieto, MJ & Sánchez-Peñarete, DC 2025, 'Salud ósea en pacientes con distrofia muscular de Duchenne', Revista Ciencias de la Salud, vol. 23, n.º Special Issue. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.13614

TY - JOUR

T1 - Salud ósea en pacientes con distrofia muscular de Duchenne

AU - Lasprilla-Tovar, Juan David

AU - Prieto, Juan Carlos

AU - Barajas-Viracachá, Norma Carolina

AU - Becerra-Ortiz, Paulo César

AU - Bobadilla-Quesada, Edna Julieth

AU - Bolaños-Almeida, Carlos Ernesto

AU - Cañón-Zambrano, José Manuel

AU - Castellar-Leones, Sandra Milena

AU - Huertas-Quiñones, Manuel

AU - Jurado-Hernández, Jenny Libeth

AU - Laza-Gutiérrez, Nicolás J.

AU - Londoño Ossa, Isabel C.

AU - Ortiz-Giraldo, Blair

AU - Ortiz-Corredor, Fernando

AU - Ospina-Lagos, Sandra Janeth

AU - Rivera-Nieto, Carolina

AU - Ruiz-Ospina, Edicson

AU - Ruiz-Botero, Felipe

AU - Salcedo-Maldonado, María Claudia

AU - Soto-Peña, Diana Pilar

AU - Suárez-Obando, Fernando

AU - Tavera-Saldaña, Lina Marcela

AU - Torres-Nieto, María Julia

AU - Sánchez-Peñarete, Diana Carolina

PY - 2025/4/22

Y1 - 2025/4/22

N2 - Patients with Duchenne muscular dystrophy are treated with glucocorticoids aiming to modify the natural history of the disease. However, their prolonged use is associated with growth disturbances, alterations in skeletal development and increased fracture rates. Additionally, patients with Duchenne muscular dystrophy have increased bone fragility with changes in bone mass that may or may not be the result of glucocorticoid use. This fragility increases the risk of fractures, thus necessitating proper diagnosis, follow-up, and treatment of these patients. This review describes how to adequately assess and manage bone health in patients with dmd. © 2025, Universidad del Rosario. All rights reserved.

AB - Patients with Duchenne muscular dystrophy are treated with glucocorticoids aiming to modify the natural history of the disease. However, their prolonged use is associated with growth disturbances, alterations in skeletal development and increased fracture rates. Additionally, patients with Duchenne muscular dystrophy have increased bone fragility with changes in bone mass that may or may not be the result of glucocorticoid use. This fragility increases the risk of fractures, thus necessitating proper diagnosis, follow-up, and treatment of these patients. This review describes how to adequately assess and manage bone health in patients with dmd. © 2025, Universidad del Rosario. All rights reserved.

KW - Duchenne muscular dystrophy

KW - bone

KW - health

UR - https://www.scopus.com/pages/publications/105007607024

U2 - 10.12804/revistas.urosario.edu.co/revsalud/a.13614

DO - 10.12804/revistas.urosario.edu.co/revsalud/a.13614

M3 - Artículo

AN - SCOPUS:105007607024

SN - 1692-7273

VL - 23

JO - Revista Ciencias de la Salud

JF - Revista Ciencias de la Salud

IS - Special Issue

ER -

Salud ósea en pacientes con distrofia muscular de Duchenne

Resumen

Palabras clave

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto